Navigenics is pleased to announce the appointment of a new company leader. Here are some details, as described in a news release:
Navigenics, a leading personal genomics testing company, announced today that Jonathan “Jack” T. Lord, M.D., has been appointed by the Board of Directors to serve as President and Chief Executive Officer of the firm.
Dr. Lord brings to Navigenics a history and passion for combining robust medical science with technological innovation to improve consumers’ health and access to quality care. Dr. Lord comes to Navigenics from Louisville, Kentucky-based Humana, Inc., where as Chief Innovation Officer he was responsible for designing new products and services to enable people to navigate the healthcare system and support their health needs. Before Humana, Dr. Lord was president of Health Dialog in Boston, where he helped pioneer e-enabled health care. He has also served as chief operating officer of the American Hospital Association in Washington, D.C. Previously, Dr. Lord was executive vice president of Anne Arundel Medical Center in Annapolis, MD, and executive vice president of Sun Health in Charlotte, NC.
“I am excited about the prospects of leading a company that will transform healthcare. Navigenics’ leadership in science, its exceptionally committed and leading edge investors, and strong management team make this the most exciting opportunity of my career,” said Dr. Lord. “Passion for advancing personalized medicine defines Navigenics. I am very honored to have the privilege to lead this company as we transform healthcare for the 21st century– an era of healthcare we hope will be marked by a focus on prediction and prevention.”